Two Sigma Advisers’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-7,040
| Closed | -$49.7K | – | 2587 |
|
|
2022
Q4 | $49.7K | Sell |
7,040
-2,130
| -23% | -$15K | ﹤0.01% | 2362 |
|
|
2022
Q3 | $139K | Buy |
9,170
+440
| +5% | +$6.67K | ﹤0.01% | 2264 |
|
|
2022
Q2 | $87K | Sell |
8,730
-36,530
| -81% | -$364K | ﹤0.01% | 2404 |
|
|
2022
Q1 | $652K | Buy |
45,260
+8,800
| +24% | +$127K | ﹤0.01% | 1852 |
|
|
2021
Q4 | $1.9M | Buy |
36,460
+31,020
| +570% | +$1.62M | ﹤0.01% | 1227 |
|
|
2021
Q3 | $317K | Sell |
5,440
-4,780
| -47% | -$279K | ﹤0.01% | 2093 |
|
|
2021
Q2 | $824K | Sell |
10,220
-3,130
| -23% | -$252K | ﹤0.01% | 1719 |
|
|
2021
Q1 | $1.11M | Buy |
13,350
+1,190
| +10% | +$99K | ﹤0.01% | 1601 |
|
|
2020
Q4 | $922K | Buy |
12,160
+9,500
| +357% | +$720K | ﹤0.01% | 1602 |
|
|
2020
Q3 | $284K | Sell |
2,660
-7,390
| -74% | -$789K | ﹤0.01% | 2030 |
|
|
2020
Q2 | $1.52M | Buy |
10,050
+4,890
| +95% | +$742K | ﹤0.01% | 1359 |
|
|
2020
Q1 | $430K | Buy |
5,160
+3,530
| +217% | +$294K | ﹤0.01% | 1863 |
|
|
2019
Q4 | $275K | Buy |
+1,630
| New | +$275K | ﹤0.01% | 2091 |
|